• PeopleBio’s controlling holder group kept 31,072,236 shares, though its stake fell to 57.69% from 58.75% as shares outstanding rose.
• Disclosure cited new contracts involving perpetual convertible bonds, plus additional share-pledge arrangements.
• Shares under major contracts were unchanged at 19,007,457, though the ratio slipped to 35.29% from 35.94%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PeopleBio Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261008000693), on October 08, 2026, and is solely responsible for the information contained therein.